PDB Short entry for 2P1L HEADER APOPTOSIS 05-MAR-07 2P1L TITLE STRUCTURE OF THE BCL-XL:BECLIN 1 COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: APOPTOSIS REGULATOR BCL-X; COMPND 3 CHAIN: A, C, E, G; COMPND 4 FRAGMENT: BCL-XL DELTA-LOOP; COMPND 5 SYNONYM: BCL-XL; BCL-2-LIKE 1 PROTEIN; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BECLIN 1; COMPND 10 CHAIN: B, D, F, H; COMPND 11 FRAGMENT: BECLIN 1; COMPND 12 SYNONYM: COILED-COIL MYOSIN-LIKE BCL2-INTERACTING PROTEIN; PROTEIN COMPND 13 GT197; COMPND 14 ENGINEERED: YES; COMPND 15 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BCL2L1, BCL2L, BCLX; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSF; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 GENE: BECN1, GT197; SOURCE 16 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 18 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 20 EXPRESSION_SYSTEM_PLASMID: PGEX-2T KEYWDS APOPTOSIS; AUTOPHAGY; BECLIN; BH3 DOMAIN; BCL, APOPTOSIS EXPDTA X-RAY DIFFRACTION AUTHOR P.D.JEFFREY,Y.SHI,A.L.OBERSTEIN REVDAT 4 26-JUL-17 2P1L 1 SOURCE REMARK REVDAT 3 24-FEB-09 2P1L 1 VERSN REVDAT 2 05-JUN-07 2P1L 1 JRNL REVDAT 1 13-MAR-07 2P1L 0 JRNL AUTH A.OBERSTEIN,P.D.JEFFREY,Y.SHI JRNL TITL CRYSTAL STRUCTURE OF THE BCL-XL-BECLIN 1 PEPTIDE COMPLEX: JRNL TITL 2 BECLIN 1 IS A NOVEL BH3-ONLY PROTEIN JRNL REF J.BIOL.CHEM. V. 282 13123 2007 JRNL REFN ISSN 0021-9258 JRNL PMID 17337444 JRNL DOI 10.1074/JBC.M700492200 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.73 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1611649.830 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 41260 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.262 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2107 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 6487 REMARK 3 BIN R VALUE (WORKING SET) : 0.3020 REMARK 3 BIN FREE R VALUE : 0.3500 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.30 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 360 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.018 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5284 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 16 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 54.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 60.40 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -6.03000 REMARK 3 B22 (A**2) : 19.33000 REMARK 3 B33 (A**2) : -13.29000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.29 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.38 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.400 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 18.50 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.000 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.34 REMARK 3 BSOL : 36.97 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2P1L COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-MAR-07. REMARK 100 THE DEPOSITION ID IS D_1000041852. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : SILICON REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46829 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 100.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 3.990 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07100 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.49 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.41300 REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 65.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.59 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% (W/V) PEG-400, 0.1M HEPES PH7.5, REMARK 280 0.2M SODIUM CITRATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 53.97000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 55.29500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 53.97000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 55.29500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: UNIQUE HETERODIMERIC COMPLEX IS FORMED BETWEEN CHAINS A AND REMARK 300 B, (BCL-XL AND BECLIN 1 RESPECTIVELY). A DIMER OF HETERODIMERS IS REMARK 300 FORMED BETWEEN THE A+B AND C+D COMPLEXES VIA A DOMAIN-SWAPPED REMARK 300 HELIX. THERE ARE TWO OF THESE "DIMERS OF HETERODIMERS" IN THE REMARK 300 ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2090 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2070 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9740 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9660 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 9580 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: HEXADECAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 38600 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 55280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -258.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -110.59000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 3 -1.000000 0.000000 0.000000 -53.97000 REMARK 350 BIOMT2 3 0.000000 1.000000 0.000000 -55.29500 REMARK 350 BIOMT3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 350 BIOMT1 4 1.000000 0.000000 0.000000 53.97000 REMARK 350 BIOMT2 4 0.000000 -1.000000 0.000000 -55.29500 REMARK 350 BIOMT3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8520 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14970 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -55.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 8380 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -52.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 199 REMARK 465 ALA A 200 REMARK 465 ALA A 201 REMARK 465 GLU A 202 REMARK 465 SER A 203 REMARK 465 ARG A 204 REMARK 465 LYS A 205 REMARK 465 GLY A 206 REMARK 465 GLN A 207 REMARK 465 GLU A 208 REMARK 465 ARG A 209 REMARK 465 GLN B 129 REMARK 465 THR B 130 REMARK 465 ASP B 131 REMARK 465 VAL B 132 REMARK 465 ASP B 133 REMARK 465 HIS B 134 REMARK 465 PRO B 135 REMARK 465 MET C 1 REMARK 465 ALA C 199 REMARK 465 ALA C 200 REMARK 465 ALA C 201 REMARK 465 GLU C 202 REMARK 465 SER C 203 REMARK 465 ARG C 204 REMARK 465 LYS C 205 REMARK 465 GLY C 206 REMARK 465 GLN C 207 REMARK 465 GLU C 208 REMARK 465 ARG C 209 REMARK 465 GLN D 129 REMARK 465 THR D 130 REMARK 465 ASP D 131 REMARK 465 VAL D 132 REMARK 465 ASP D 133 REMARK 465 HIS D 134 REMARK 465 PRO D 135 REMARK 465 MET E 1 REMARK 465 ALA E 199 REMARK 465 ALA E 200 REMARK 465 ALA E 201 REMARK 465 GLU E 202 REMARK 465 SER E 203 REMARK 465 ARG E 204 REMARK 465 LYS E 205 REMARK 465 GLY E 206 REMARK 465 GLN E 207 REMARK 465 GLU E 208 REMARK 465 ARG E 209 REMARK 465 GLN F 129 REMARK 465 THR F 130 REMARK 465 ASP F 131 REMARK 465 VAL F 132 REMARK 465 ASP F 133 REMARK 465 HIS F 134 REMARK 465 PRO F 135 REMARK 465 MET G 1 REMARK 465 ALA G 199 REMARK 465 ALA G 200 REMARK 465 ALA G 201 REMARK 465 GLU G 202 REMARK 465 SER G 203 REMARK 465 ARG G 204 REMARK 465 LYS G 205 REMARK 465 GLY G 206 REMARK 465 GLN G 207 REMARK 465 GLU G 208 REMARK 465 ARG G 209 REMARK 465 GLN H 129 REMARK 465 THR H 130 REMARK 465 ASP H 131 REMARK 465 VAL H 132 REMARK 465 ASP H 133 REMARK 465 HIS H 134 REMARK 465 PRO H 135 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU G 174 CA - CB - CG ANGL. DEV. = 14.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 107 125.26 -2.28 REMARK 500 THR A 109 -97.00 -64.28 REMARK 500 GLN A 111 -57.90 -164.78 REMARK 500 ASP C 107 120.66 5.38 REMARK 500 THR C 109 -101.02 -63.25 REMARK 500 GLN C 111 -62.51 -159.99 REMARK 500 ASP C 133 40.14 -108.27 REMARK 500 GLN E 3 -76.27 -142.80 REMARK 500 SER E 4 100.53 -48.37 REMARK 500 ASP E 107 123.79 -1.28 REMARK 500 THR E 109 -94.46 -64.67 REMARK 500 GLN E 111 -67.20 -163.50 REMARK 500 ASP E 133 31.28 -99.09 REMARK 500 PHE G 105 -159.51 -125.07 REMARK 500 ASP G 107 120.38 7.87 REMARK 500 THR G 109 -93.89 -64.89 REMARK 500 GLN G 111 -64.81 -165.30 REMARK 500 ASP G 133 44.27 -100.82 REMARK 500 REMARK 500 REMARK: NULL DBREF 2P1L A 1 26 UNP Q07817 BCLX_HUMAN 1 26 DBREF 2P1L C 1 26 UNP Q07817 BCLX_HUMAN 1 26 DBREF 2P1L E 1 26 UNP Q07817 BCLX_HUMAN 1 26 DBREF 2P1L G 1 26 UNP Q07817 BCLX_HUMAN 1 26 DBREF 2P1L A 83 209 UNP Q07817 BCLX_HUMAN 83 209 DBREF 2P1L C 83 209 UNP Q07817 BCLX_HUMAN 83 209 DBREF 2P1L E 83 209 UNP Q07817 BCLX_HUMAN 83 209 DBREF 2P1L G 83 209 UNP Q07817 BCLX_HUMAN 83 209 DBREF 2P1L B 107 135 UNP Q14457 BCN1_HUMAN 107 135 DBREF 2P1L D 107 135 UNP Q14457 BCN1_HUMAN 107 135 DBREF 2P1L F 107 135 UNP Q14457 BCN1_HUMAN 107 135 DBREF 2P1L H 107 135 UNP Q14457 BCN1_HUMAN 107 135 SEQADV 2P1L GLY B 105 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L SER B 106 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L GLY D 105 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L SER D 106 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L GLY F 105 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L SER F 106 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L GLY H 105 UNP Q14457 CLONING ARTIFACT SEQADV 2P1L SER H 106 UNP Q14457 CLONING ARTIFACT SEQRES 1 A 153 MET SER GLN SER ASN ARG GLU LEU VAL VAL ASP PHE LEU SEQRES 2 A 153 SER TYR LYS LEU SER GLN LYS GLY TYR SER TRP SER GLN SEQRES 3 A 153 MET ALA ALA VAL LYS GLN ALA LEU ARG GLU ALA GLY ASP SEQRES 4 A 153 GLU PHE GLU LEU ARG TYR ARG ARG ALA PHE SER ASP LEU SEQRES 5 A 153 THR SER GLN LEU HIS ILE THR PRO GLY THR ALA TYR GLN SEQRES 6 A 153 SER PHE GLU GLN VAL VAL ASN GLU LEU PHE ARG ASP GLY SEQRES 7 A 153 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE SER PHE GLY SEQRES 8 A 153 GLY ALA LEU CYS VAL GLU SER VAL ASP LYS GLU MET GLN SEQRES 9 A 153 VAL LEU VAL SER ARG ILE ALA ALA TRP MET ALA THR TYR SEQRES 10 A 153 LEU ASN ASP HIS LEU GLU PRO TRP ILE GLN GLU ASN GLY SEQRES 11 A 153 GLY TRP ASP THR PHE VAL GLU LEU TYR GLY ASN ASN ALA SEQRES 12 A 153 ALA ALA GLU SER ARG LYS GLY GLN GLU ARG SEQRES 1 B 31 GLY SER GLY THR MET GLU ASN LEU SER ARG ARG LEU LYS SEQRES 2 B 31 VAL THR GLY ASP LEU PHE ASP ILE MET SER GLY GLN THR SEQRES 3 B 31 ASP VAL ASP HIS PRO SEQRES 1 C 153 MET SER GLN SER ASN ARG GLU LEU VAL VAL ASP PHE LEU SEQRES 2 C 153 SER TYR LYS LEU SER GLN LYS GLY TYR SER TRP SER GLN SEQRES 3 C 153 MET ALA ALA VAL LYS GLN ALA LEU ARG GLU ALA GLY ASP SEQRES 4 C 153 GLU PHE GLU LEU ARG TYR ARG ARG ALA PHE SER ASP LEU SEQRES 5 C 153 THR SER GLN LEU HIS ILE THR PRO GLY THR ALA TYR GLN SEQRES 6 C 153 SER PHE GLU GLN VAL VAL ASN GLU LEU PHE ARG ASP GLY SEQRES 7 C 153 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE SER PHE GLY SEQRES 8 C 153 GLY ALA LEU CYS VAL GLU SER VAL ASP LYS GLU MET GLN SEQRES 9 C 153 VAL LEU VAL SER ARG ILE ALA ALA TRP MET ALA THR TYR SEQRES 10 C 153 LEU ASN ASP HIS LEU GLU PRO TRP ILE GLN GLU ASN GLY SEQRES 11 C 153 GLY TRP ASP THR PHE VAL GLU LEU TYR GLY ASN ASN ALA SEQRES 12 C 153 ALA ALA GLU SER ARG LYS GLY GLN GLU ARG SEQRES 1 D 31 GLY SER GLY THR MET GLU ASN LEU SER ARG ARG LEU LYS SEQRES 2 D 31 VAL THR GLY ASP LEU PHE ASP ILE MET SER GLY GLN THR SEQRES 3 D 31 ASP VAL ASP HIS PRO SEQRES 1 E 153 MET SER GLN SER ASN ARG GLU LEU VAL VAL ASP PHE LEU SEQRES 2 E 153 SER TYR LYS LEU SER GLN LYS GLY TYR SER TRP SER GLN SEQRES 3 E 153 MET ALA ALA VAL LYS GLN ALA LEU ARG GLU ALA GLY ASP SEQRES 4 E 153 GLU PHE GLU LEU ARG TYR ARG ARG ALA PHE SER ASP LEU SEQRES 5 E 153 THR SER GLN LEU HIS ILE THR PRO GLY THR ALA TYR GLN SEQRES 6 E 153 SER PHE GLU GLN VAL VAL ASN GLU LEU PHE ARG ASP GLY SEQRES 7 E 153 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE SER PHE GLY SEQRES 8 E 153 GLY ALA LEU CYS VAL GLU SER VAL ASP LYS GLU MET GLN SEQRES 9 E 153 VAL LEU VAL SER ARG ILE ALA ALA TRP MET ALA THR TYR SEQRES 10 E 153 LEU ASN ASP HIS LEU GLU PRO TRP ILE GLN GLU ASN GLY SEQRES 11 E 153 GLY TRP ASP THR PHE VAL GLU LEU TYR GLY ASN ASN ALA SEQRES 12 E 153 ALA ALA GLU SER ARG LYS GLY GLN GLU ARG SEQRES 1 F 31 GLY SER GLY THR MET GLU ASN LEU SER ARG ARG LEU LYS SEQRES 2 F 31 VAL THR GLY ASP LEU PHE ASP ILE MET SER GLY GLN THR SEQRES 3 F 31 ASP VAL ASP HIS PRO SEQRES 1 G 153 MET SER GLN SER ASN ARG GLU LEU VAL VAL ASP PHE LEU SEQRES 2 G 153 SER TYR LYS LEU SER GLN LYS GLY TYR SER TRP SER GLN SEQRES 3 G 153 MET ALA ALA VAL LYS GLN ALA LEU ARG GLU ALA GLY ASP SEQRES 4 G 153 GLU PHE GLU LEU ARG TYR ARG ARG ALA PHE SER ASP LEU SEQRES 5 G 153 THR SER GLN LEU HIS ILE THR PRO GLY THR ALA TYR GLN SEQRES 6 G 153 SER PHE GLU GLN VAL VAL ASN GLU LEU PHE ARG ASP GLY SEQRES 7 G 153 VAL ASN TRP GLY ARG ILE VAL ALA PHE PHE SER PHE GLY SEQRES 8 G 153 GLY ALA LEU CYS VAL GLU SER VAL ASP LYS GLU MET GLN SEQRES 9 G 153 VAL LEU VAL SER ARG ILE ALA ALA TRP MET ALA THR TYR SEQRES 10 G 153 LEU ASN ASP HIS LEU GLU PRO TRP ILE GLN GLU ASN GLY SEQRES 11 G 153 GLY TRP ASP THR PHE VAL GLU LEU TYR GLY ASN ASN ALA SEQRES 12 G 153 ALA ALA GLU SER ARG LYS GLY GLN GLU ARG SEQRES 1 H 31 GLY SER GLY THR MET GLU ASN LEU SER ARG ARG LEU LYS SEQRES 2 H 31 VAL THR GLY ASP LEU PHE ASP ILE MET SER GLY GLN THR SEQRES 3 H 31 ASP VAL ASP HIS PRO FORMUL 9 HOH *16(H2 O) HELIX 1 1 SER A 2 GLN A 19 1 18 HELIX 2 2 SER A 25 ARG A 103 1 23 HELIX 3 3 THR A 115 PHE A 131 1 17 HELIX 4 4 ASN A 136 LYS A 157 1 22 HELIX 5 5 VAL A 161 LEU A 178 1 18 HELIX 6 6 LEU A 178 ASN A 185 1 8 HELIX 7 7 GLY A 186 GLY A 196 1 11 HELIX 8 8 SER B 106 MET B 126 1 21 HELIX 9 9 SER C 2 GLN C 19 1 18 HELIX 10 10 SER C 25 ARG C 103 1 23 HELIX 11 11 THR C 118 ARG C 132 1 15 HELIX 12 12 ASN C 136 LYS C 157 1 22 HELIX 13 13 VAL C 161 LEU C 178 1 18 HELIX 14 14 LEU C 178 ASN C 185 1 8 HELIX 15 15 GLY C 186 GLY C 196 1 11 HELIX 16 16 SER D 106 MET D 126 1 21 HELIX 17 17 SER E 4 GLN E 19 1 16 HELIX 18 18 SER E 25 ARG E 103 1 23 HELIX 19 19 THR E 118 PHE E 131 1 14 HELIX 20 20 ASN E 136 LYS E 157 1 22 HELIX 21 21 VAL E 161 LEU E 178 1 18 HELIX 22 22 LEU E 178 ASN E 185 1 8 HELIX 23 23 GLY E 186 GLY E 196 1 11 HELIX 24 24 SER F 106 MET F 126 1 21 HELIX 25 25 SER G 2 GLN G 19 1 18 HELIX 26 26 SER G 25 ARG G 103 1 23 HELIX 27 27 THR G 118 PHE G 131 1 14 HELIX 28 28 ASN G 136 LYS G 157 1 22 HELIX 29 29 GLN G 160 LEU G 178 1 19 HELIX 30 30 LEU G 178 ASN G 185 1 8 HELIX 31 31 GLY G 186 GLY G 196 1 11 HELIX 32 32 SER H 106 MET H 126 1 21 CRYST1 107.940 110.590 100.520 90.00 90.00 90.00 P 21 21 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009264 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009042 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009948 0.00000